Evidence map›Paper›PMID 41482367›Full record

ArticleIn vivo (Athens, Greece)

Frequency and Diagnostic Utility of the -13910C>T

Guilherme Passos DE Morais, André Pontes Thé, Beatriz Maria Dias Nogueira, Deivide DE Sousa Oliveira, Leidivan Sousa DA Cunha, Jean Breno Silveira DA Silva, Patrícia Maria Pontes Thé, Alexandre DE Almeida Monteiro, Luis Gonzaga Moura Xavier, Maria Elisabete Amaral DE Moraes and 1 more

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Integrative Multi-omics Analysis for Prioritization of Candidate Genes in Polycystic Ovary Syndrome.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guilherme Passos DE Morais *Department of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
André Pontes Thé *Department of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
Beatriz Maria Dias NogueiraDepartment of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
Deivide DE Sousa OliveiraDepartment of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
Leidivan Sousa DA CunhaDepartment of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
Jean Breno Silveira DA SilvaGenomics and Molecular Biology Laboratory, Central Unity, Clementino Fraga Group, Fortaleza, CE, Brazil.
Patrícia Maria Pontes ThéDepartment of Pharmacy, Federal University of Ceará, Fortaleza, CE, Brazil.
Alexandre DE Almeida MonteiroDepartment of Clinical Pathology, Central Unity, Clementino Fraga Group, Fortaleza, CE, Brazil.
Luis Gonzaga Moura XavierDepartment of Clinical Pathology, Central Unity, Clementino Fraga Group, Fortaleza, CE, Brazil.
Maria Elisabete Amaral DE MoraesDepartment of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
Caroline Aquino Moreira-NunesDepartment of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil; carolfam@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimLactose intolerance (LI) is a common clinical condition associated with reduced lactase enzyme activity. The oral lactose tolerance test (OLTT), although widely used for diagnosis, has several limitations such as fasting, multiple blood collections, and gastrointestinal discomfort. As an alternative, genetic testing targeting the -13910C>T polymorphism in the MATERIALS AND

methodsA descriptive study was conducted with data from 2359 patients examined between January 2022 and May 2025 at a private laboratory. Concordance between genotyping and OLTT was analyzed in 24 patients who underwent both tests, with OLTT considered the reference standard. Sensitivity, specificity, accuracy, and Kappa coefficient were calculated. All analyses were performed using R software.

resultsThe median age of participants was 7 years (range=0.06-100 years). The observed genotype frequencies were 52.90% for the CC genotype, 38.74% for CT, and 8.35% for TT. The Kappa test demonstrated moderate agreement between the genetic test and OLTT [k=0.583 (

conclusionGenotyping for the -13910C>T polymorphism in the

Indexed as

Genetic Predisposition to DiseaseLactose IntoleranceMinichromosome Maintenance Complex Component 6Polymorphism, Single NucleotideAdolescentAdultAgedAged, 80 and overBrazilChildChild, PreschoolFemaleGene FrequencyGenotypeHumansInfantMCM6 protein, humanMinichromosome Maintenance Complex Component 6gene polymorphismgenetic testingLactase non-persistencelactose intolerancemolecular diagnostics

Identifiers

PMID41482367
PMCPMC12764234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.